• Skip to primary navigation
  • Skip to main content
  • Skip to footer

TVM Capital Life Science Venture Capital

Investing in Life Science Innovation

  • About Us
    • Partners
  • Team
  • Senior Advisors
  • Portfolio
  • Funding Request
  • News
  • Events
  • ESG Policy
  • Contact

Strongbridge Biopharma

  • Home
  • About Us
  • Team
  • Senior Advisors
  • Portfolio
  • News
  • Events
  • ESG Policy
  • Contact
strongbridge

Strongbridge Biopharma

Exit 2020
Visit Website

We are called Strongbridge for a reason. We’re building a strong clinical and financial foundation to connect patients with new treatments for rare diseases.

Strongbridge is committed to bridging treatment gaps as rapidly as possible. We are building rare disease franchises that aim to utilize accelerated regulatory pathways when possible.

The Strongbridge leadership team exemplifies the company’s approach—rare focus, rare commitment, and rare passion.

 

 

  • in

Copyright © 2023 · TVM Capital Life Science Venture Capital · ESG Disclosure · Privacy Policy · Contact